Automate eCOA Migration with GlobalLink XCompare

Reduce eCOA migration errors by 97% with XCompare technology that automates your development and migration workflows.

Schedule a Demo
COA Migration

Faster Migration, Fully Compliant

XCompare’s automated development and translation workflows help clinical teams accelerate COA migrations while significantly reducing errors.

  • Control eCOA language quality during development
  • Guarantee accuracy of translated eCOA content for adapted and existing text
  • Export fully auditable and controlled reports
  • Use any file type
  • Reduce project delays
  • Reduce rounds of screenshot reviews

Mitigate eCOA Migration Risk without Delaying Your Study

As life sciences companies transition from traditional COA administration to electronic processes, TransPerfect’s GlobalLink XCompare™ technology straightens the path for eCOA adaptation and COA migration. Streamline your COA migration and mitigate risk with eCOA automation. Our proprietary solution makes ensuring accuracy and compliance of eCOA content easier and faster for your clinical team.

Manual Migration vs. XCompare Technology

Human-Led Migration

✘ Traditional migration methods include several lengthy manual processes, including manual copy/paste and manual reviews, which are prone to error.

XCompare Technology

✓ GlobalLink XCompare automates manual migration processes, reduces errors by 97%, and speeds up eCOA migration timelines by 50%.

Manual Paper Comparison Key

Create a manual source key to identify all the similarities and differences between pen/paper to the electronic version.

Automated Migration

GlobalLink XCompare uses artificial intelligence (AI) to detect changes between paper and electronic versions and present them in a user-friendly report.

Manual Migration Process

Copy and paste the text manually into an electronic format while trying to implement adaptations.

Subject matter experts are required to do a manual review of every word, making it hard to identify slight deviations.

Automatic Track Changes

All changes are tracked in a comprehensive log for easy scanning, review, error identification, and decision-making.

Manual Quality Control

Relies on tedious, error-prone manual quality control checks across multiple versions of your documents and source key.

Consistent and Objective Quality Control

GlobalLink XCompare detects changes between the proposed target content and the approved paper versions, automatically flagging errors in the electronic translation when no discrepancies are present in the electronic source.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of more than 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

Biogen
Evidera/PPD
untitled_design_3.png
AstraZeneca

eCOA Migration Automation by the Numbers


97 %

Reduction in migration errors

50 %

Reduction in review rounds

2.5 x

Decrease in screenshot compare time

globallinklogo

GlobalLink is the world’s most flexible translation management system. Since its introduction in 1999, TransPerfect’s GlobalLink translation management technology has helped many of the world’s leading life sciences organizations simplify the process of creating, releasing, and managing multilingual content.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

Governing AI for Global Content in the Life Sciences Industry

AI is already shaping the content that reaches patients, healthcare professionals, and regulators, often through tools that were never built for regulated use. But adoption alone doesn’t create control, and a single terminology error or untraceable approval can put compliance and patient trust at risk. This guide lays out a practical operating model for governed AI in life sciences: measure quality across every language, route content by risk, and build the audit ...

Governing AI for Global Content in the Life Sciences Industry

Reddit Stories: AI Failures in Clinical Trials

Clinical operations experts react to real AI failure stories pulled directly from Reddit and work backward to identify what should have caught them. From hallucinated citations that passed an initial review to AI-drafted guidance sent to a site without proper oversight, each ...

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....

The Human in the Vault: Building Review Workflows That Satisfy Regulators

AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process ...

eConsent: Why the Content Matters as Much as the Tech

Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind...

Pragmatic Use Cases for AI in Medical Information

The rapid advancement of AI presents medical information teams with powerful new opportunities to transform their operations. From inquiry intake and intelligent triage to case management and standard response development, AI-driven solutions are already delivering measurable ...

LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients

Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, ...

Are you launching a study with eCOA?

Now is the right time to engage with us. Our AI-powered eCOA migration automation reduces risk of errors by 97%, supports lean turnaround times, and delivers a fully compliant paper scale digitization. Talk with our experts about migrating your paper COAs with accuracy, timeliness, and compliance.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.